AI assistant
AGRONOMICS LIMITED — Net Asset Value 2014
Jul 22, 2014
7474_rns_2014-07-22_6fb4a7cd-217f-46cd-868a-d917ded160ea.html
Net Asset Value
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9245M
Port Erin Biopharma Investments Ltd
22 July 2014
For immediate release 22 July 2014
Port Erin Biopharma Investments Limited
(the "Company")
Net Asset Value calculation to 30 June 2014
Jim Mellon, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2014 was 14.71 pence per share, including un-invested cash of £526,503 and an accrual carried forward of £379,057 for the management fee. The portfolio is valued under IFRS at bid price.
Thus in the full year, Total Assets have grown in value by 37.1% to just under £5.0 million, and Investments have grown in value by 65.6% to £4.8 million. This quarter's NAV represents a decrease of 4.5% from the previous valuation of 15.40 pence per share, which included un-invested cash of £736,392. On this basis, no additional management fee is due to Shellbay Investments Limited.
Our holding in the Magna Biopharma Income Fund continues to perform well, the value having risen by 7.0% to £2.9 million in the six months since inception."
| Unaudited to 30 June 2014 £ |
||
| Fixed Assets | ||
| Investments | 4,830,908 | |
| Current Assets | ||
| Debtors: amounts owing | 24,997 | |
| Un-invested cash | 526,503 | |
| Current Liabilities | ||
| Creditors: amounts due | (400,982) | |
| 4,981,426 | ||
| Capital and Reserves | ||
| Share Capital | 34 | |
| Share Premium | 2,759,551 | |
| Current year's earnings | 1,381,475 | |
| Retained earnings | 840,366 | |
| 4,981,426 | ||
| Shares in Issue | 33,864,836 | |
| Asset Value per share | 14.71 pence | |
--- ENDS ---
Portfolio Details
| Investments as at 30 June 2014 | Value | % of Total Portfolio |
| Magna Biopharma Income Fund | £2,901,683 | 60.06% |
| Plethora Solutions Holdings | £852,500 | 17.65% |
| Summit Corporation | £536,667 | 11.11% |
| Other quoted holdings | £163,938 | 3.39% |
| Other unquoted holdings | £376,120 | 7.79% |
| Total | £4,830,908 | 100.00% |
For further information, please contact:
| Port Erin Biopharma Investments Limited | Beaumont Cornish Limited | Peterhouse Capital Limited |
| The Company | Nomad | Broker |
| Denham Eke +44 162 463 9396 |
Roland Cornish +44 207 628 3396 |
Jon Levinson +44 207 469 0935 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVGMGZNLMZGDZM